The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $2.52

Today's change0.00 0.00%
Updated June 24 2:48 PM -4GMT. Delayed by at least 15 minutes.
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $2.52

Today's change0.00 0.00%
Updated June 24 2:48 PM -4GMT. Delayed by at least 15 minutes.

Cleveland Biolabs Inc closed at (U.S.)$2.52.

Over the last five days, shares have gained 0.80%, but are down 27.79% for the last year to date. Shares have underperformed the S&P 500 by 49.49% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.52
  • High--
  • Low--
  • Bid / Ask(U.S.) $2.41 / (U.S.) $3.00
  • YTD % change-27.79%
  • Volume0
  • Average volume (10-day)10,057
  • Average volume (1-month)15,830
  • Average volume (3-month)22,778
  • 52-week range(U.S.) $1.92 to (U.S.) $5.29
  • Beta1.01
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.62
Updated June 24 2:48 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1110
Total other revenue--------
Total revenue1110
Gross profit--------
Total cost of revenue--------
Total operating expense3333
Selling / general / administrative1112
Research & development2222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0----
Other operating expenses, total--------
Operating income-2-2-3-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-2-3-4
Income after tax-1-2-3-4
Income tax, total--------
Net income-1-1-3-4
Total adjustments to net income--------
Net income before extra. items-1-1-3-4
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-3-4
Inc. avail. to common incl. extra. items-1-1-3-4
Diluted net income-1-1-3-4
Dilution adjustment--------
Diluted weighted average shares1111104
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.13-0.31-1.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.06-0.13-0.31-1.12